IO360 ̊ convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
The 6th annual Immuno-Oncology 360° Summit is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate.
The 3 day summit features more than 80 time sensitive IO topics, over 500 senior level thought leaders and includes over 10 hours of networking.
New for 2020:
● Cell & Gene Therapy Day – A full day on February 27th dedicated to Cell & Gene Therapy for Solid Tumors. Chaired by Dr Aiman Shalabi, GSK. Keynotes, Cornerstone and Notable Speakers include Dr Carl June, UPenn, Dr Crystal Mackall, Stanford University, Dr Arie Belldegrun, Allogene, Dr Peter Marks, FDA, Dr Stephanie Goff, NCI, amongst many more.
● Cancer Immunotherapy Debates – This new style of presentation for IO360° features counterpoint views from leading experts on current controversial clinical issues in IO. Two experts will present the argument and counter-argument in support of two different points of view related to the topic at hand. Debates are sprinkled throughout the agenda over the course of the 3 days.
2020 Plenary Topics
● Discovery/Preclinical Science
● Imaging Aspects
● Clinical Operations
● Business Developments
● Translational Science
● Emerging Biomarkers
● IO Novel Technologies
● AI & Machine Learning
● Clinical Developments
Use the code ARM20 for a 20% discount.
For more information please visit: www.io360summit.com